Ahmadabadi, F. et al. 2022. The Efficacy of Addition of Atomoxetine to Speech Therapy on the Stuttering Severity of Children Aged 4-12 Years; a Double-Blind Controlled Randomized Clinical Trial. Iranian Journal of Child Neurology. 16, 3 (Jul. 2022), 47–56. DOI:https://doi.org/10.22037/ijcn.v16i3.34450.